首页> 外国专利> Menoragia was treated with 18-methyl-15,16-methyl-en-19-nor-20-helix-4-en-3-onas and including 18-methyl-15-methyl-19-nor-20-helix-4-en-3-onas for uterine bleeding disorders

Menoragia was treated with 18-methyl-15,16-methyl-en-19-nor-20-helix-4-en-3-onas and including 18-methyl-15-methyl-19-nor-20-helix-4-en-3-onas for uterine bleeding disorders

机译:月经过多用18-甲基-15,16-甲基-en-19-nor-20-螺旋-4-en-3-onas和包括18-甲基-15-甲基-19-nor-20-螺旋-4处理-en-3-onas用于子宫出血疾病

摘要

18-methyl-15 ß;, 16 ß; - methyl-19-nor-20-helix-4-en-3-perfluorooctane sulfonic acid (1), wherein R6 and R7 are hydrogen or a methamphetamine group for the treatment of intrauterine bleeding and the use of intrauterine contraceptives, including a formula 1.
机译:18-methyl-15ß;, 16ß; -甲基-19-nor-20-螺旋-4-en-3-全氟辛烷磺酸(1),其中R6和R7是氢或甲基苯丙胺基团,用于治疗子宫内出血和使用宫内避孕药,包括1。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号